Search

The Co-Founder of AI Proteins explains the benefits of designing de novo miniproteins as therapeutics
Chris Bahl walks through the attributes of miniproteins.
Apr 25, 2024
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.